Online Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- Keywords
- Capillary electrophoresis, Cytochrome P450 3A4, Drug metabolism, Enantioselective separation, Enzyme inhibition, In-capillary reactor, Ketamine, Transverse diffusion of laminar flow profiles,
- MeSH
- Cytochrome P-450 CYP3A metabolism MeSH
- Electrophoresis, Capillary methods MeSH
- Cytochrome P-450 CYP3A Inhibitors pharmacology MeSH
- Ketamine analogs & derivatives pharmacology MeSH
- Kinetics MeSH
- Humans MeSH
- Mass Screening methods MeSH
- Stereoisomerism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Cytochrome P-450 CYP3A MeSH
- Cytochrome P-450 CYP3A Inhibitors MeSH
- Ketamine MeSH
- norketamine MeSH Browser
The market share of single-enantiomer drugs is steadily increasing. The pharmacodynamics and pharmacokinetics of individual enantiomers can differ considerably. Thus, their characteristics have to be addressed as early as possible in the development process of new pharmaceuticals. Capillary electrophoresis is a promising technique for enantioselective drug metabolism studies due to highly effective separations, minuscule consumption of sample and reagents, compatibility with a variety of detection techniques, high-throughput via automation, and the implementation of online procedures. An online method comprised of the diffusion-based mixing of cytochrome P450 3A4 with racemic ketamine, incubation of the enzyme reaction, separation of the reaction products S- and R-norketamine, and their quantification is presented in this chapter. Since diffusion is an inherent property of all molecules, the method enables the addition of virtually any compound to the reaction mixture without the need for additional optimization of the mixing conditions, and thus can be favorably used for the rapid screening of putative cytochrome P450 3A4 inhibitors.
References provided by Crossref.org